key: cord-1012781-ntgtq6na
authors: Tannenbaum, Rachel; Rekhtman, Sergey; Strunk, Andrew; Birabaharan, Morgan; Shaigany, Sheila; Burshtein, Joshua; Grbic, Nicole; Nazir, Zaeem; Norden, Alexandra; Godfred-Cato, Shana; Belay, Ermias; Patel, Pragna; Garg, Amit
title: Mucocutaneous Manifestations Among Adults Hospitalized With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection
date: 2022-01-24
journal: JAAD Int
DOI: 10.1016/j.jdin.2022.01.005
sha: 5c0b97d5400f75e7fe71400df62b0cb1cc6b5f98
doc_id: 1012781
cord_uid: ntgtq6na

Among adults hospitalized for severe illness with probable MIS-A, 6 patients with hyperinflammation had mucocutaneous involvement, most commonly with purpura.

We previously performed a prospective study wherein hospitalized adults with COVID-19 at 59 Northwell Health underwent integumentary examination. We estimated prevalence of rash, characterized 60 its morphology, and described related clinical courses for children and adolescents with COVID-19 and 61 MIS-C, 4 and adults with COVID-19. 5 In collaboration with the CDC, we postulated that applying working 

Influence of mucocutaneous disease on higher mortality observed in our MIS-A cohort is unclear.

Higher mortality reported herein compared to that reported in other MIS-A cohorts may also be related to 

Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection -United Kingdom and United States

Coronavirus disease 2019 acute myocarditis and multisystem inflammatory syndrome in adult intensive and cardiac care units

Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children

Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19